CoChat
Sign Up
Cited by 150interferon and immune responsesImmune Response and InflammationImmunotherapy and Immune Responses

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells

Open access
Wimmers, Florian, Subedi, Nikita, van Buuringen, Nicole, Heister, Daan, Vivié, Judith, Beeren-Reinieren, Inge, Woestenenk, Rob, Dolstra, Harry, Piruska, Aigars, Jacobs, Joannes F. M., van Oudenaarden, Alexander, Figdor, Carl G., Huck, Wilhelm T. S., de Vries, I. Jolanda M., Tel, Jurjen·2018·Nature Communications
DOI 10.1038/s41467-018-05784-3PMC PMC6102223
Open this paper in CoChat — free accountOpen PDF

Abstract

Type I interferon (IFN) is a key driver of immunity to infections and cancer. Plasmacytoid dendritic cells (pDCs) are uniquely equipped to produce large quantities of type I IFN but the mechanisms that control this process are poorly understood. Here we report on a droplet-based microfluidic platform to investigate type I IFN production in human pDCs at the single-cell level. We show that type I IFN but not TNFα production is limited to a small subpopulation of individually stimulated pDCs and controlled by stochastic gene regulation. Combining single-cell cytokine analysis with single-cell RNA-seq profiling reveals no evidence for a pre-existing subset of type I IFN-producing pDCs. By modulating the droplet microenvironment, we demonstrate that vigorous pDC population responses are driven by a type I IFN amplification loop. Our study highlights the significance of stochastic gene regulation and suggests strategies to dissect the characteristics of immune responses at the single-cell level.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-05784-3

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Single-cell analysis reveals functional heterogeneity within individually stimulated pDCs. a Schematic overview of the droplet microfluidic assay. The pDCs were coated with cytokine capture reagents, encapsulated in picoliter droplets, and stimulated with TLR ligands. After incubation, cells were stained for viability, cytokine, and surface marker expression, and analyzed by flow cytometry. b Schematic overview of the employed microfluidic chip with microscopic image of the flow-focusing nozzle for the encapsulation of cells in droplets. c Microscopic image of emulsion after droplet production. b, c Red arrows indicate cells. Scale bars equal 100 µm. d The pDCs were encapsulated at a concentration of 1,300,000 cells/mL in 92 pL droplets. The distribution of cells in droplets was measured by manual analysis of microscopic images showing the emulsion directly after production. Shown is the fraction of droplets plotted against the number of cells per droplet; n = 85, black line indicates median, red line indicates predicted values. e Shown is the fraction of cell-containing droplets with exactly one cell; n = 85. Lines indicate mean, hinges mark interquartile ranges, and whiskers reach to the highest/lowest value that is within 1.5 × interquartile range. f–k The pDCs were treated as described above and stimulated with 5 μg/mL or 50 µg/mL CpG-C. f Viable pDCs were detected by forward scatter (FSC) and side scatter (SSC) analysis and subsequent gating on CD14−CD19− and viability dye− cells. g IFNα- and TNFα-secreting cells were detected within that population. h Shown is the fraction of cytokine-secreting cells plotted against incubation time; n (5 µg/mL) = 3, n (50 µg/mL) = 6. i Surface marker-expressing pDCs were identified comparing the expression levels to fluorescence-minus-one controls. j Shown is the fraction of surface marker-expressing cells plotted against the incubation time; n > = 4. k The co-expression of CCR7, CD40, CD86, and TNFα by single IFNα+ and IFNα− pDCs was analyzed. Shown is the relative contribution of each functional response pattern to the total pDC population. h, j Dots indicate mean, error bars indicate SEM
Fig. 1 Single-cell analysis reveals functional heterogeneity within individually stimulated pDCs. a Schematic overview of the droplet microfluidic assay. The pDCs were coated with cytokine capture reagents, encapsulated in picoliter droplets, and stimulated with TLR ligands. After incubation, cells were stained for viability, cytokine, and surface marker expression, and analyzed by flow cytometry. b Schematic overview of the employed microfluidic chip with microscopic image of the flow-focusing nozzle for the encapsulation of cells in droplets. c Microscopic image of emulsion after droplet production. b, c Red arrows indicate cells. Scale bars equal 100 µm. d The pDCs were encapsulated at a concentration of 1,300,000 cells/mL in 92 pL droplets. The distribution of cells in droplets was measured by manual analysis of microscopic images showing the emulsion directly after production. Shown is the fraction of droplets plotted against the number of cells per droplet; n = 85, black line indicates median, red line indicates predicted values. e Shown is the fraction of cell-containing droplets with exactly one cell; n = 85. Lines indicate mean, hinges mark interquartile ranges, and whiskers reach to the highest/lowest value that is within 1.5 × interquartile range. f–k The pDCs were treated as described above and stimulated with 5 μg/mL or 50 µg/mL CpG-C. f Viable pDCs were detected by forward scatter (FSC) and side scatter (SSC) analysis and subsequent gating on CD14−CD19− and viability dye− cells. g IFNα- and TNFα-secreting cells were detected within that population. h Shown is the fraction of cytokine-secreting cells plotted against incubation time; n (5 µg/mL) = 3, n (50 µg/mL) = 6. i Surface marker-expressing pDCs were identified comparing the expression levels to fluorescence-minus-one controls. j Shown is the fraction of surface marker-expressing cells plotted against the incubation time; n > = 4. k The co-expression of CCR7, CD40, CD86, and TNFα by single IFNα+ and IFNα− pDCs was analyzed. Shown is the relative contribution of each functional response pattern to the total pDC population. h, j Dots indicate mean, error bars indicate SEMCC BY · PubMed Central
Fig. 2 TLR-L concentration does not influence the fraction of IFNα-producing pDCs in droplets. a, b The pDCs were coated with capture reagent, encapsulated in picoliter droplets, and stimulated individually with a CpG-C or b R848 for 12 h. After staining for viability, surface marker expression and cytokine secretion, cytokine-secreting cells, and viable cells were detected via flow cytometry. Shown is the fraction of marker-expressing cells plotted against TLR ligand concentration. Different concentrations were tested in different donors; a n ≥ 3, b n ≥ 2. c The pDCs were treated as described above and stimulated with 0.01 µg/mL IL- 3 or 50 µg/mL CpG-C. Shown is the fraction of cytokine-secreting cells plotted against treatment condition; n = 5. Bars indicate mean. d The pDCs were treated as described above and stimulated with 50 µg/mL CpG-C for 12 h or 24 h. Shown is the fraction of IFNα-secreting or viable cells plotted against treatment condition; n = 8 (c, d) Mann–Whitney test *p < 0.05, **p < 0.01
Fig. 2 TLR-L concentration does not influence the fraction of IFNα-producing pDCs in droplets. a, b The pDCs were coated with capture reagent, encapsulated in picoliter droplets, and stimulated individually with a CpG-C or b R848 for 12 h. After staining for viability, surface marker expression and cytokine secretion, cytokine-secreting cells, and viable cells were detected via flow cytometry. Shown is the fraction of marker-expressing cells plotted against TLR ligand concentration. Different concentrations were tested in different donors; a n ≥ 3, b n ≥ 2. c The pDCs were treated as described above and stimulated with 0.01 µg/mL IL- 3 or 50 µg/mL CpG-C. Shown is the fraction of cytokine-secreting cells plotted against treatment condition; n = 5. Bars indicate mean. d The pDCs were treated as described above and stimulated with 50 µg/mL CpG-C for 12 h or 24 h. Shown is the fraction of IFNα-secreting or viable cells plotted against treatment condition; n = 8 (c, d) Mann–Whitney test *p < 0.05, **p < 0.01CC BY · PubMed Central
Fig. 3 Single-cell RNA-sequencing identifies type I IFN-expressing cells early after activation. a The pDCs were coated with capture reagent, encapsulated in picoliter droplets, and stimulated individually with 50 µg/mL CpG-C for varying amounts of time. b After staining for surface marker expression and cytokine secretion, different pDC subsets were collected using fluorescence-activated cell sorting (FACS) and their transcriptomes were sequenced using the SORT-Seq protocol. c Heat map of the 774 cells that passed quality control filters representing transcriptome similarities as measured by Euclidean distance. The k-medoid clustering in combination with the raceID2 algorithm identified 8 distinct cell clusters. d t-SNE map showing all identified clusters. Different colors indicate clusters, different shapes indicate stimulation time. e The employed workflow allowed to link protein expression data acquired during FACS to the transcriptome data. The number of IFNα+ cells assigned to each cluster, and the percentage of sorted IFNα+ cells in each cluster, is plotted against the cluster name. f t-SNE map showing the fluorescence intensity of IFNα and TNFα as measured during FACS for each cell. g Shown are transcript counts for genes of the type I IFN response and the TNF gene in single cells stimulated for 2 h with CpG-C. IFNα+ cells, identified during FACS, are indicated in blue, other cells are shown in red. h Genes that were upregulated in cluster 5 compared to cells from all other clusters were detected (p < 10−8). Shown is the log2(fold change) for each gene. The color scale indicates the corresponding p value
Fig. 3 Single-cell RNA-sequencing identifies type I IFN-expressing cells early after activation. a The pDCs were coated with capture reagent, encapsulated in picoliter droplets, and stimulated individually with 50 µg/mL CpG-C for varying amounts of time. b After staining for surface marker expression and cytokine secretion, different pDC subsets were collected using fluorescence-activated cell sorting (FACS) and their transcriptomes were sequenced using the SORT-Seq protocol. c Heat map of the 774 cells that passed quality control filters representing transcriptome similarities as measured by Euclidean distance. The k-medoid clustering in combination with the raceID2 algorithm identified 8 distinct cell clusters. d t-SNE map showing all identified clusters. Different colors indicate clusters, different shapes indicate stimulation time. e The employed workflow allowed to link protein expression data acquired during FACS to the transcriptome data. The number of IFNα+ cells assigned to each cluster, and the percentage of sorted IFNα+ cells in each cluster, is plotted against the cluster name. f t-SNE map showing the fluorescence intensity of IFNα and TNFα as measured during FACS for each cell. g Shown are transcript counts for genes of the type I IFN response and the TNF gene in single cells stimulated for 2 h with CpG-C. IFNα+ cells, identified during FACS, are indicated in blue, other cells are shown in red. h Genes that were upregulated in cluster 5 compared to cells from all other clusters were detected (p < 10−8). Shown is the log2(fold change) for each gene. The color scale indicates the corresponding p valueCC BY · PubMed Central
Fig. 4 Type I IFN-expressing pDCs show unique gene expression patterns. a Differentially regulated genes in cells from all activated clusters compared to cluster 1 were identified. Differentially regulated genes from cluster 5. The average log2(count) of each gene is plotted against the log2(fold change) compared to cells in Cl1. Red color indicates p value < 10−8. b The top 30 most upregulated genes are shown for cluster 5. Shown is the log2 fold change for each gene. The color scale indicates the average log2(Count) for each transcript in Cl5. c Venn diagram of the upregulated genes (log2(fold change) > 1.5, p value < 10−8) within different clusters. d Lists of upregulated genes were submitted to DAVID for GO enrichment analysis and KEGG enrichment analysis. Heat maps show the most significantly enriched terms for the gene list from cluster 5. The color scale indicates the significance of enrichment of a particular term in all selected clusters after Benjamini–Hochberg correction for multiple testing
Fig. 4 Type I IFN-expressing pDCs show unique gene expression patterns. a Differentially regulated genes in cells from all activated clusters compared to cluster 1 were identified. Differentially regulated genes from cluster 5. The average log2(count) of each gene is plotted against the log2(fold change) compared to cells in Cl1. Red color indicates p value < 10−8. b The top 30 most upregulated genes are shown for cluster 5. Shown is the log2 fold change for each gene. The color scale indicates the average log2(Count) for each transcript in Cl5. c Venn diagram of the upregulated genes (log2(fold change) > 1.5, p value < 10−8) within different clusters. d Lists of upregulated genes were submitted to DAVID for GO enrichment analysis and KEGG enrichment analysis. Heat maps show the most significantly enriched terms for the gene list from cluster 5. The color scale indicates the significance of enrichment of a particular term in all selected clusters after Benjamini–Hochberg correction for multiple testingCC BY · PubMed Central
Fig. 5 Microenvironmental factors influence the fraction of IFNα-producing pDCs. a, b The pDCs were coated with cytokine capture reagents, encapsulated in droplets of varying size (b, scale bar equals 100 µm), and stimulated individually with 50 µg/mL CpG-C for 12 h. The distribution of cells in droplets was measured by manual analysis of microscopic images after production. After staining for viability and surface marker expression, viable cells and TNFα-positive cells were detected via flow cytometry. c Shown is the fraction of cell-containing droplets with exactly one cell; n > = 3. Lines indicate mean, hinges mark interquartile ranges, and whiskers reach to the highest/lowest value that is within 1.5 × interquartile range. d The fraction of IFNα-secreting pDCs was plotted against droplet volume. Dots of the same color indicate cells from the same donor. Gray dots are all originating from different donors. Linear regression was employed to calculate a trend line; n = 24. a, e The pDCs were stimulated in ~92 pL droplets with an increasing fraction of droplets containing more than 1 cell. f Shown is the fraction of IFNα-secreting cells plotted against the fraction of droplets containing more than 1 cell. Two models were generated to explain the observed pattern: (red) two random pDCs co-encapsulated in the same droplet can induce type I IFN production in each other; (blue) rare early type I IFN-producing cells can induce type I IFN production in conventional co-encapsulated cells. The root-square-mean error (RMSE) was calculated for both models to compare the fit to the data; n = 24. g Schematic overview of both models
Fig. 5 Microenvironmental factors influence the fraction of IFNα-producing pDCs. a, b The pDCs were coated with cytokine capture reagents, encapsulated in droplets of varying size (b, scale bar equals 100 µm), and stimulated individually with 50 µg/mL CpG-C for 12 h. The distribution of cells in droplets was measured by manual analysis of microscopic images after production. After staining for viability and surface marker expression, viable cells and TNFα-positive cells were detected via flow cytometry. c Shown is the fraction of cell-containing droplets with exactly one cell; n > = 3. Lines indicate mean, hinges mark interquartile ranges, and whiskers reach to the highest/lowest value that is within 1.5 × interquartile range. d The fraction of IFNα-secreting pDCs was plotted against droplet volume. Dots of the same color indicate cells from the same donor. Gray dots are all originating from different donors. Linear regression was employed to calculate a trend line; n = 24. a, e The pDCs were stimulated in ~92 pL droplets with an increasing fraction of droplets containing more than 1 cell. f Shown is the fraction of IFNα-secreting cells plotted against the fraction of droplets containing more than 1 cell. Two models were generated to explain the observed pattern: (red) two random pDCs co-encapsulated in the same droplet can induce type I IFN production in each other; (blue) rare early type I IFN-producing cells can induce type I IFN production in conventional co-encapsulated cells. The root-square-mean error (RMSE) was calculated for both models to compare the fit to the data; n = 24. g Schematic overview of both modelsCC BY · PubMed Central
Fig. 6 The pDCs primed with CM or IFNβ are more likely to produce IFNα. a Schematic overview of the priming experiment. The pDCs were stimulated for 2 h with conditioned medium (CM), 0.5 µg/mL CpG-C, or control medium. Cells were washed, coated with cytokine capture reagent, encapsulated in droplets, and stimulated individually with 0.01 µg/mL IL-3 or 50 µg/mL CpG-C for 12 h. CM was generated from bulk pDC cultures stimulated with 5 µg/mL CpG-C at a density of 25,000 cells/well. Cytokine-secreting cells were detected using flow cytometry. b The fraction of IFNα-secreting cells is plotted against different treatment conditions. c Co-expression of CCR7, CD40, CD86, and TNFα by single IFNα+ and IFNα− pDCs was analyzed. Shown is the relative contribution of each functional response pattern to the total pDC population. d The pDCs were primed with different concentrations of CM and stimulated with 50 µg/mL CpG-C. Shown is the fraction of IFNα-secreting cells plotted against CM concentration; n > = 3. Dots indicate mean and whiskers indicate SEM. e The pDCs were treated as described above, primed with 10% CM, and stimulated with different concentrations of CpG-C. Shown is the fraction of IFNα-secreting cells plotted against CpG-C concentration; n = 3. f The pDCs were primed with 10% CM, control medium, or 500 U/mL IFNβ, and stimulated with 50 µg/mL CpG-C. The fraction of IFNα-secreting cells is plotted against different treatment conditions; n > = 3. g Schematic model illustrating stochastic IFNα-production by pDCs. Few pDCs produce IFNα constitutively without stimulation by TLR ligands, here resembled by differentiation from a freshly isolated pDC (pDC0) to an IFNα-secreting pDC (pDC1). Literature indicates that this is not IRF7 dependent but NF-κB and AP-127. Upon TLR9 triggering the IRF7-dependent pathway is activated which also allows differentiation to IFNα-secreting pDC at a much higher rate. Despite involvement of the IRF7 pathway, still only very few pDCs produce IFNα. Paracrine signaling via the type I IFN receptor can increase this rate, probably via the upregulation of IRF7 expression, leading to a large fraction of cells expressing IFNα. After producing IFNα, pDCs become refractory to re-stimulation (pDC2) and eventually die (Φ). b, f Welch-corrected two-sample t-test; *p < 0.05, **p < 0.01
Fig. 6 The pDCs primed with CM or IFNβ are more likely to produce IFNα. a Schematic overview of the priming experiment. The pDCs were stimulated for 2 h with conditioned medium (CM), 0.5 µg/mL CpG-C, or control medium. Cells were washed, coated with cytokine capture reagent, encapsulated in droplets, and stimulated individually with 0.01 µg/mL IL-3 or 50 µg/mL CpG-C for 12 h. CM was generated from bulk pDC cultures stimulated with 5 µg/mL CpG-C at a density of 25,000 cells/well. Cytokine-secreting cells were detected using flow cytometry. b The fraction of IFNα-secreting cells is plotted against different treatment conditions. c Co-expression of CCR7, CD40, CD86, and TNFα by single IFNα+ and IFNα− pDCs was analyzed. Shown is the relative contribution of each functional response pattern to the total pDC population. d The pDCs were primed with different concentrations of CM and stimulated with 50 µg/mL CpG-C. Shown is the fraction of IFNα-secreting cells plotted against CM concentration; n > = 3. Dots indicate mean and whiskers indicate SEM. e The pDCs were treated as described above, primed with 10% CM, and stimulated with different concentrations of CpG-C. Shown is the fraction of IFNα-secreting cells plotted against CpG-C concentration; n = 3. f The pDCs were primed with 10% CM, control medium, or 500 U/mL IFNβ, and stimulated with 50 µg/mL CpG-C. The fraction of IFNα-secreting cells is plotted against different treatment conditions; n > = 3. g Schematic model illustrating stochastic IFNα-production by pDCs. Few pDCs produce IFNα constitutively without stimulation by TLR ligands, here resembled by differentiation from a freshly isolated pDC (pDC0) to an IFNα-secreting pDC (pDC1). Literature indicates that this is not IRF7 dependent but NF-κB and AP-127. Upon TLR9 triggering the IRF7-dependent pathway is activated which also allows differentiation to IFNα-secreting pDC at a much higher rate. Despite involvement of the IRF7 pathway, still only very few pDCs produce IFNα. Paracrine signaling via the type I IFN receptor can increase this rate, probably via the upregulation of IRF7 expression, leading to a large fraction of cells expressing IFNα. After producing IFNα, pDCs become refractory to re-stimulation (pDC2) and eventually die (Φ). b, f Welch-corrected two-sample t-test; *p < 0.05, **p < 0.01CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

Sorted by citations

See all 150

Related

Metadata

Authors
Wimmers, F., Subedi, N., van Buuringen, N., Heister, D., Vivié, J., Beeren-Reinieren, I., Woestenenk, R., Dolstra, H., Piruska, A., Jacobs, J. F. M., van Oudenaarden, A., Figdor, C. G., Huck, W. T. S., de Vries, I. J. M., & Tel, J.
Affiliations
  • Radboud University Medical Center (NL)
  • Eindhoven University of Technology (NL)
  • University Medical Center Utrecht (NL)
  • Radboud University Nijmegen (NL)
Corresponding author
Tel, Jurjen
ORCID
Venue
Nature Communications
Publisher
Springer Science and Business Media LLC
Published
2018-08-20
Volume
9
Issue
1
Pages
3317-3317
ISSN
2041-1723 (ISSN-L)
DOI
10.1038/s41467-018-05784-3
PMC
PMC6102223
OpenAlex
W2885999695
Cited by
150
References
53
Citations by year
2026: 3 · 2025: 17 · 2024: 11 · 2023: 26 · 2022: 21 · 2021: 24 · 2020: 20 · 2019: 26 · 2018: 2
FWCI
7.68
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
  • TU/e Research Portal (acceptedVersion, other-oa)
  • TU/e Research Portal (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
  • TU/e Research Portal (submittedVersion, other-oa)
Funders
  • Radboud Universitair Medisch Centrum (PhD grant)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (863.130.24, Spinoza Award, Spinoza award)
  • Generous support by the Eindhoven University of Technology
  • Ministerie van Onderwijs, Cultuur en Wetenschap (024.001.035)
  • generous support by the Radboud University
  • KWF Kankerbestrijding (2009-4402)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
plasmacytoid dendritic cells, type I interferon, interferon-alpha production, stochastic gene regulation, paracrine signaling, droplet microfluidics, single-cell RNA sequencing, TNF-α, immune response heterogeneity
MeSH terms
Dendritic Cells, Gene Expression Regulation, Humans, Interferon Type I, Stochastic Processes, Sequence Analysis, RNA, Jurkat Cells, Paracrine Communication, Cross-Priming, Toll-Like Receptors, Single-Cell Analysis, Cellular Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review